LYNDSEY MATHIAS: Open Payments
NPI 1619453602 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 49 payments from 17 companies in 2025. Trend: 2023 $704 · 2024 $1,013 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $195 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Dexcom, Inc. | 4 | $148 |
| Novo Nordisk Inc | 5 | $81 |
| PFIZER INC. | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $62 |
| ABBVIE INC. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $41 |
| Zimmer Biomet Holdings, Inc. | 1 | $38 |
| Amgen Inc. | 2 | $35 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, ZEPBOUND, MOUNJARO, XIFAXAN, JARDIANCE, NURTEC ODT, Ozempic.
Industry payments across SC — which companies pay providers there.
